Phase 2 Study Initiated: ALTO-101 for Cognitive Impairment With Schizophrenia

9 Likes

Curious - a PDE4 inhibitor. I’ve read of PDE inhibitors being researched as add-on therapy in depression, for instance, cilostazol, which increased the response rate in depressive patients who were receiving escitalopram as their “main” drug, compared to “escitalopram + placebo”.